Sodium-glucose co-transporter-2 inhibitors are a class of antihyperglycemic agents that can be used to improve glycemic control in the treatment of type 2 diabetes.
Jessica L. Kerr, PharmD, CDE
Advertisement
Articles by Jessica L. Kerr, PharmD, CDE
This Continuing Education activity is supported by an educational grant from Novo Nordisk.
Advertisement
Latest Updated Articles
Pharmacists Reaching Out in Diabetes: Optimizing Insulin Therapy Through Patient Engagement and ManagementPublished: April 18th 2016 | Updated:
Sodium-Glucose Co-Transporter-2 Inhibitors: An Update on the Evidence for Treatment of Type 2 DiabetesPublished: October 13th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
2
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
3
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
4
Medetomidine: The Demon in the Illicit Fentanyl Supply
5
